Get started
Author

Alexander D. Borowsky

Aneuploidy selects for the acquisition of driver genes in breast cancer
2026 · Khalid N. Al-Zahrani, Ellen R. Langille, et al. · Nature · 3
A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer
2026 · Charles X. Wang, Guillaume Luxardi, et al. · OncoImmunology
PDF
Neoadjuvant rilvegostomig (R) + trastuzumab deruxtecan (T-DXd) in high-risk HER2-negative breast cancer: Results from the I-SPY 2.2 trial.
2026 · Ciara Catherine O'Sullivan, Kevin Kalinsky, et al. · Journal of Clinical Oncology
Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations
2026 · Yiwey Shieh, Rachel S. Heise, et al. · JAMA Oncology
Impact of age on breast cancer outcomes in the neoadjuvant I-SPY2 trial.
2026 · Kelsey H. Natsuhara, Cynthia Wu, et al. · Journal of Clinical Oncology
Neoadjuvant DAN-222 plus niraparib in high-risk HER2-negative breast cancer: Results from the I-SPY 2 adaptive platform trial.
2026 · Kay T. Yeung, Claudine Isaacs, et al. · Journal of Clinical Oncology
A Distinct Host-Microbiome Signature Underlies the Accelerated Malignant Potential of Colorectal Laterally Spreading Tumors
2026 · Tymofiy Lutsiv, Henry J. Thompson, et al. · Gastro Hep Advances
A human breast cell model of pre-invasive to invasive transition
2008 · Bissell, Mina J, Rizki, Aylin, et al. · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
PDF
Works count: 8
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type